Carregant...
RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
The first therapeutic nucleic acid, a DNA oligonucleotide, was approved for clinical use in 1998. Twenty years later, in 2018, the first therapeutic RNA-based oligonucleotide was United States Food and Drug Administration (FDA) approved. This promises to be a rapidly expanding market, as many emergi...
Guardat en:
| Publicat a: | Cells |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7016530/ https://ncbi.nlm.nih.gov/pubmed/31936122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9010137 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|